CHINA PHARMA HOLDINGS, INC. (CPHI) › Operating IncomeCHINA PHARMA HOLDINGS, INC. (CPHI) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: $24.66M2011: $22.03M2012: $5.91M2013: -$18.61M2014: -$38.76M2015: -$14.30M2016: -$8.16M2017: -$18.68M2018: -$10.45M2019: -$20.41M2020: -$2.58M2021: -$2.86M2022: -$3.55M2023: -$2.75M2024: -$4.59M2025: -$3.24M-$3.24M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$3.24M+29.4%2024-$4.59M-66.8%2023-$2.75M+22.5%2022-$3.55M-24.1%2021-$2.86M-10.9%2020-$2.58M+87.4%2019-$20.41M-95.3%2018-$10.45M+44.1%2017-$18.68M-129.0%2016-$8.16M+43.0%2015-$14.30M+63.1%2014-$38.76M-108.3%2013-$18.61M-415.1%2012$5.91M-73.2%2011$22.03M-10.7%2010$24.66M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share